topiramate

NDC 82009-137 · Quallent Pharmaceuticals Health LLC

Generic nametopiramate

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength100 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

82009-137-05 — 500 TABLET, FILM COATED in 1 BOTTLE (82009-137-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

76282-281 — Topiramate, 76420-276 — Topiramate, 76420-278 — Topiramate, 76420-279 — Topiramate, 76420-280 — Topiramate, 80425-0092 — Topiramate, 80425-0195 — Topiramate, 80425-0208 — Topiramate, 80425-0214 — Topiramate, 80425-0288 — Topiramate, 80425-0373 — Topiramate, 80425-0398 — topiramate, 80425-0488 — topiramate, 80425-0495 — topiramate, 80425-0576 — topiramate, 81033-035 — TOPIRAMATE, 82009-135 — topiramate, 82009-136 — topiramate, 83008-011 — topiramate, 87441-079 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels